A multiphase contrast-enhanced CT radiomics model for prediction of human epidermal growth factor receptor 2 status in advanced gastric cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multiphase contrast-enhanced CT radiomics model for prediction of human epidermal growth factor receptor 2 status in advanced gastric cancer
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-10-07
DOI
10.3389/fgene.2022.968027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
- (2022) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer
- (2020) Yanfen Cui et al. EUROPEAN RADIOLOGY
- The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma
- (2020) Wei Zhao et al. Frontiers in Oncology
- CT Radiomics for Distinction of Human Epidermal Growth Factor Receptor 2 Negative Gastric Cancer
- (2020) Yue Wang et al. ACADEMIC RADIOLOGY
- A CT-based Radiomics Model for Prediction of Lymph Node Metastasis in Early Stage Gastric Cancer
- (2020) Xujie Gao et al. ACADEMIC RADIOLOGY
- Radiomics of multi-parametric MRI for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study
- (2019) Zhenyu Liu et al. CLINICAL CANCER RESEARCH
- Artificial intelligence in cancer imaging: Clinical challenges and applications
- (2019) Wenya Linda Bi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bone Marrow and Tumor Radiomics at 18F-FDG PET/CT: Impact on Outcome Prediction in Non–Small Cell Lung Cancer
- (2019) Sarah A. Mattonen et al. RADIOLOGY
- Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
- (2018) Takeru Wakatsuki et al. JOURNAL OF GASTROENTEROLOGY
- Prognostic implications of HER2 heterogeneity in gastric cancer
- (2018) Shigenobu Motoshima et al. Oncotarget
- Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection
- (2018) Wuchao Li et al. EUROPEAN RADIOLOGY
- Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
- (2018) Shusuke Yagi et al. Gastric Cancer
- The relationship between HER2 overexpression and angiogenesis in gastric cancer
- (2018) Maciej Ciesielski et al. MEDICINE
- CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
- (2018) Dongdong Mei et al. CANCER IMAGING
- CT-based radiomics signature for differentiating Borrmann type IV gastric cancer from primary gastric lymphoma
- (2017) Zelan Ma et al. EUROPEAN JOURNAL OF RADIOLOGY
- Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial
- (2016) Jifang Gong et al. BMC CANCER
- Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer
- (2016) Yan-qi Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Heterogeneity in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Assessed by CT Texture Analysis: Association with Survival after Trastuzumab Treatment
- (2016) Sung Hyun Yoon et al. PLoS One
- Magnetic resonance imaging texture analysis classification of primary breast cancer
- (2015) S. A. Waugh et al. EUROPEAN RADIOLOGY
- Assessment of a HER2 scoring system for colorectal cancer: results from a validation study
- (2015) Emanuele Valtorta et al. MODERN PATHOLOGY
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- A novel gene–protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity
- (2014) Yasunori Nishida et al. Gastric Cancer
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
- (2014) Hugo J. W. L. Aerts et al. Nature Communications
- HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: A prospective cohort observation
- (2013) Miao-Zhen Qiu et al. INTERNATIONAL JOURNAL OF CANCER
- Locally Advanced Squamous Cell Carcinoma of the Head and Neck: CT Texture and Histogram Analysis Allow Independent Prediction of Overall Survival in Patients Treated with Induction Chemotherapy
- (2013) Haowei Zhang et al. RADIOLOGY
- Quantifying tumour heterogeneity with CT
- (2013) Balaji Ganeshan et al. CANCER IMAGING
- Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
- (2012) Hee Eun Lee et al. EUROPEAN JOURNAL OF CANCER
- MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells
- (2012) C.-T. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: Preliminary evidence of an association with tumour metabolism, stage, and survival
- (2011) B. Ganeshan et al. CLINICAL RADIOLOGY
- Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival
- (2011) Balaji Ganeshan et al. EUROPEAN RADIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now